EUVIMEDObjevte EUVIMED
Klinische StudieOpen access

MyPainPal, a Novel mHealth App to Improve Pain in Patients With Advanced Cancer: Single-Arm Pilot Study

Desiree R Azizoddin iD, Michael Hassett iD, Kris-Ann S Anderson iD, Daniela Kessler iD, Alexi Wright iD, Madeline Gorra iD, Benjamin Kematick iD, Isaac Chua iD, Douglas Brandoff iD, Kate Lally iD, Lida Nabati iD, Susan MacIsaac iD and 2 more

JMIR Cancer · 2025-12-30 · 11 · e79942

DOI: 10.2196/79942 ↗

At a glance

Klinische Studie in JMIR Cancer, published online on 2025-12-30. Written by Desiree R Azizoddin and 13 co-authors. Institution: Department of Supportive Oncology, Dana-Farber Cancer Institute, Boston, MA, United States. Major MEDLINE topics: Cancer Pain, Mobile Applications, Neoplasms, Pain Management. Cited 2 times so far (Crossref); 51 references. The full text is freely available in PubMed Central. Funded by: NINR NIH HHS.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Pain is common among patients with advanced cancer and is often inadequately controlled. Opioids are central to treatment; yet, self-management is challenging, and clinicians lack scalable tools to monitor and support patients between visits.

Objective

This study aimed to evaluate the feasibility and acceptability of MyPainPal (Dana-Faber Cancer Institute), a novel mobile health app designed to optimize cancer pain management. MyPainPal combines daily surveys assessing symptoms and analgesic use, algorithmic self-management support, tailored psychoeducation, and clinician monitoring. Secondary objectives were to explore preliminary clinical impact and identify priorities for refinement.

Methods

This single-arm pilot study enrolled adults with advanced malignancies using opioids for moderate-to-severe pain from an outpatient palliative care clinic at a comprehensive cancer center. Participants used MyPainPal for 28 days while nurses monitored symptom responses via a secure portal, and also completed structured surveys at end-of-study. Primary assessment of usability and acceptability included the System Usability Scale (SUS; range 0-100), the Acceptability E-Scale (range 6-30), and ratings of satisfaction using a 5-point Likert scale. Semistructured debriefing interviews explored user experience, perceived impact, and suggestions for optimization.

Results

Twenty participants with advanced cancer enrolled, with a mean age of 57 (SD 12.3) years, 55% (11/20) female, 80% (16/20) non-Hispanic White, with mixed cancer types. Over the 28-day study, patients logged into MyPainPal a median of 14 (IQR 8-17) times, and completed a median of 8 (IQR 5-14) symptom surveys, reflecting mean of 36% (SD 20%) of eligible (out-of-hospital) days on study. Usability and acceptability ratings of MyPainPal were high (mean SUS 78.3, SD 16.2; mean Acceptability E-Scale 24.0, SD 4.4); 79% rated overall satisfaction of greater than or equal to 4/5. Twenty percent of surveys generated an alert, prompting nurse outreach. In response, 5 participants had symptom medications changed and 2 had medication errors corrected. In debriefing interviews, many participants described that the intervention reduced barriers to pain reporting and facilitated timely and constructive interactions with care teams for symptom management. Several noted that the intervention validated their pain experience, reduced stigma around opioid use, enabled constructive conversations with providers, and promoted self-management. Patients recommended several survey modifications, including reducing their frequency and enabling more nuanced pain assessments. Participants underused the educational resources and suggested that they be featured more prominently. Some patients suggested that the MyPainPal app should be introduced earlier in patients’ cancer pain trajectory when pain needs are higher and opioid management is novel.

Conclusions

In this pilot study, MyPainPal demonstrated feasibility, acceptability, and preliminary evidence of potential clinical impact among patients with advanced cancer receiving palliative care. The app has been rebuilt and optimized with attention to patient feedback and in preparation for a future efficacy study. Trial Registration ClinicalTrials.gov NCT03717402; https://clinicaltrials.gov/study/NCT03717402

Subjects

MeSH terms (MEDLINE)

Cancer PainMobile ApplicationsNeoplasmsPain ManagementAdultAgedFemaleHumansMaleMiddle AgedAnalgesics, OpioidPalliative CarePilot ProjectsSelf-ManagementTelemedicine

Author keywords

cancerconstipationmHealthmobile healthopioidspain managementsymptom management

Substances

Analgesics, Opioid

Authors and institutions

  • Department of Supportive Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.
  • Department of Medicine, Harvard Medical School, Boston, MA, United States.
  • Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, United States.
  • OU Health, Boston, OK, United States.

ORCID profiles: Desiree R Azizoddin, Michael Hassett, Kris-Ann S Anderson, Daniela Kessler, Alexi Wright, Madeline Gorra, Benjamin Kematick, Isaac Chua, Douglas Brandoff, Kate Lally, Lida Nabati, Susan MacIsaac, James A Tulsky, Andrea Enzinger

Funding

  • NINR NIH HHS

Cite

APA

Azizoddin, D. R., Hassett, M., Anderson, K. S., Kessler, D., Wright, A., Gorra, M., Kematick, B., Chua, I., Brandoff, D., Lally, K., Nabati, L., MacIsaac, S., Tulsky, J. A., & Enzinger, A. (2025). MyPainPal, a Novel mHealth App to Improve Pain in Patients With Advanced Cancer: Single-Arm Pilot Study. JMIR Cancer, 11, e79942. https://doi.org/10.2196/79942

Vancouver

Azizoddin DR, Hassett M, Anderson KS, Kessler D, Wright A, Gorra M, et al. MyPainPal, a Novel mHealth App to Improve Pain in Patients With Advanced Cancer: Single-Arm Pilot Study. JMIR Cancer. 2025;11:e79942. doi:10.2196/79942

BibTeX
@article{Azizoddin2025,
  author = {Azizoddin, Desiree R and Hassett, Michael and Anderson, Kris-Ann S and Kessler, Daniela and Wright, Alexi and Gorra, Madeline and Kematick, Benjamin and Chua, Isaac and Brandoff, Douglas and Lally, Kate and Nabati, Lida and MacIsaac, Susan and Tulsky, James A and Enzinger, Andrea},
  title = {MyPainPal, a Novel mHealth App to Improve Pain in Patients With Advanced Cancer: Single-Arm Pilot Study},
  journal = {JMIR Cancer},
  year = {2025},
  volume = {11},
  pages = {e79942},
  doi = {10.2196/79942}
}
Start for free →